Marshall Wace North America’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$567K Buy
+7,485
New +$641K ﹤0.01% 1088
2021
Q2
Sell
-107,225
Closed -$9.51M 1606
2021
Q1
$9.51M Buy
+107,225
New +$10.6M 0.04% 406
2019
Q3
Sell
-53,938
Closed -$3.38M 1411
2019
Q2
$3.38M Buy
53,938
+52,573
+3,852% +$2.92M 0.02% 445
2019
Q1
$64K Sell
1,365
-11,849
-90% -$629K ﹤0.01% 1211
2018
Q4
$625K Buy
13,214
+5,738
+77% +$303K 0.01% 727
2018
Q3
$480K Buy
+7,476
New +$472K ﹤0.01% 709
2017
Q4
Sell
-57,590
Closed -$4.43M 1484
2017
Q3
$4.43M Buy
57,590
+37,628
+188% +$2.73M 0.03% 581
2017
Q2
$1.36M Buy
19,962
+6,495
+48% +$426K 0.01% 840
2017
Q1
$821K Buy
+13,467
New +$837K 0.01% 735

Other funds holding ITRI

Marshall Wace North America's ITRI Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Itron (ITRI) in Q3 2021: 7,485 shares worth $567K. The stake represents ﹤0.01% of the portfolio and ranks #1088 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ITRI as recently as Q1 2021.

Marshall Wace North America first reported a position in ITRI in Q1 2017 and has held it in 9 quarters since. The position peaked at $9.51M in Q1 2021. 261 funds tracked by Wall St. Rank hold ITRI as of Q3 2021.

  • Marshall Wace North America held 7,485 shares of Itron worth $567K as of Q3 2021.
  • Itron was a new Marshall Wace North America position in Q3 2021.
  • Itron made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1088 holding.
  • Marshall Wace North America first reported a position in Itron in Q1 2017 and has held it in 9 quarters since.
  • Marshall Wace North America's Itron position peaked at $9.51M in Q1 2021.
  • 261 funds tracked by Wall St. Rank held Itron as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.